Tonix Pharmaceuticals Holding Corp. (TNXP)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 5M 10M 15M Q3 '23: 4M Q4 '23: 3.8M Q1 '24: 2.5M Q2 '24: 2.2M Q3 '24: 2.8M Q4 '24: 2.6M Q1 '25: 2.4M Q2 '25: 2M Q3 '25: 3.3M Q4 '25: 5.4M Q1 '26: 6.9M Q2 '26: 13.5M Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Gross Profit Quarterly

-5M 0 5M 10M 15M Q3 '23: 1.6M Q4 '23: 1.4M Q1 '24: 822K Q2 '24: -1.2M Q3 '24: 1.3M Q4 '24: 1.4M Q1 '25: 1.5M Q2 '25: -1.3M Q3 '25: 1.9M Q4 '25: 4.3M Q1 '26: 5.3M Q2 '26: 12.8M Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-90M -60M -30M 0 30M 60M 90M Q1 '11: -513.7K Q2 '11: -355.8K Q3 '11: -1M Q4 '11: -1.5M Q1 '12: -1.2M Q2 '12: -1.7M Q3 '12: -1.7M Q4 '12: -1.9M Q1 '13: -2M Q2 '13: -2.1M Q3 '13: -3.1M Q4 '13: -3.7M Q1 '14: -5.2M Q2 '14: -6M Q3 '14: -7.4M Q4 '14: -9M Q1 '15: -9.7M Q2 '15: -11.8M Q3 '15: -13.3M Q4 '15: -13.4M Q1 '16: -14M Q2 '16: -9.8M Q3 '16: -7.6M Q4 '16: -7.5M Q1 '17: -5.1M Q2 '17: -4.8M Q3 '17: -5.8M Q4 '17: -5.5M Q1 '18: -7M Q2 '18: -6.1M Q3 '18: -5.5M Q4 '18: -7.7M Q1 '19: -6.3M Q2 '19: -5.9M Q3 '19: -7.9M Q4 '19: -8.7M Q1 '20: -7.3M Q2 '20: -14.2M Q3 '20: -12M Q4 '20: -17M Q1 '21: -20.7M Q2 '21: -23.6M Q3 '21: -18.5M Q4 '21: -29.5M Q1 '22: -26.4M Q2 '22: -23.3M Q3 '22: -29.6M Q4 '22: -32.7M Q1 '23: -33.9M Q2 '23: -29M Q3 '23: -28.1M Q4 '23: -27.3M Q1 '24: -21.4M Q2 '24: -77.3M Q3 '24: -15.6M Q4 '24: -22.5M Q1 '25: -16.1M Q2 '25: -28.3M Q3 '25: -33.1M Q4 '25: -48.3M Q1 '26: -41.5M Q2 '26: -42.5M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Net Income Quarterly

-90M -60M -30M 0 30M 60M 90M Q1 '10: -5.8K Q2 '10: -2.4K Q3 '10: -3.7K Q4 '10: -2M Q1 '11: -513.7K Q2 '11: -355.8K Q3 '11: -1M Q4 '11: -1.6M Q1 '12: -2M Q2 '12: -1.7M Q3 '12: -1.7M Q4 '12: -2.6M Q1 '13: -2M Q2 '13: -2.1M Q3 '13: -3.1M Q4 '13: -3.7M Q1 '14: -5.2M Q2 '14: -6M Q3 '14: -7.4M Q4 '14: -9M Q1 '15: -9.7M Q2 '15: -11.8M Q3 '15: -13.2M Q4 '15: -13.4M Q1 '16: -14M Q2 '16: -9.8M Q3 '16: -7.6M Q4 '16: -7.5M Q1 '17: -5.1M Q2 '17: -4.8M Q3 '17: -5.8M Q4 '17: -5.5M Q1 '18: -6.9M Q2 '18: -6.1M Q3 '18: -5.5M Q4 '18: -7.6M Q1 '19: -6.2M Q2 '19: -5.8M Q3 '19: -7.8M Q4 '19: -8.7M Q1 '20: -7.3M Q2 '20: -14.2M Q3 '20: -12M Q4 '20: -17M Q1 '21: -20.7M Q2 '21: -23.6M Q3 '21: -18.5M Q4 '21: -29.6M Q1 '22: -26.4M Q2 '22: -23.1M Q3 '22: -29M Q4 '22: -31.7M Q1 '23: -33M Q2 '23: -28.4M Q3 '23: -28M Q4 '23: -27.3M Q1 '24: -14.9M Q2 '24: -78.8M Q3 '24: -14.2M Q4 '24: -22.1M Q1 '25: -16.8M Q2 '25: -28.3M Q3 '25: -32M Q4 '25: -46.9M Q1 '26: -40.2M Q2 '26: -40.6M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

0 1.5M 3M 4.5M Q3 '23: 2.4M Q4 '23: 2.4M Q1 '24: 1.7M Q2 '24: 3.4M Q3 '24: 1.6M Q4 '24: 1.2M Q1 '25: 943K Q2 '25: 3.3M Q3 '25: 1.4M Q4 '25: 1.1M Q1 '26: 1.6M Q2 '26: 703K Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '10: -2K Q4 '10: -1.2M Q1 '11: -380.9K Q2 '11: -231.4K Q3 '11: -542 Q4 '11: -1.5M Q1 '12: -1.8M Q2 '12: -1.1M Q3 '12: -1.3M Q4 '12: -1.5M Q1 '13: -1.4M Q2 '13: -761.4K Q3 '13: -2.9M Q4 '13: -3.5M Q1 '14: -4.1M Q2 '14: -5.7M Q3 '14: -4.9M Q4 '14: -8.2M Q1 '15: -9.1M Q2 '15: -9.2M Q3 '15: -12.3M Q4 '15: -11.9M Q1 '16: -15.5M Q2 '16: -8M Q3 '16: -8.4M Q4 '16: -5.4M Q1 '17: -4.8M Q2 '17: -4.4M Q3 '17: -5M Q4 '17: -4.9M Q1 '18: -6.8M Q2 '18: -5.5M Q3 '18: -4.9M Q4 '18: -6.8M Q1 '19: -8.6M Q2 '19: -4.7M Q3 '19: -6.6M Q4 '19: -6.7M Q1 '20: -9.3M Q2 '20: -10M Q3 '20: -15.3M Q4 '20: -13.9M Q1 '21: -21.1M Q2 '21: -19.1M Q3 '21: -12.9M Q4 '21: -22.4M Q1 '22: -31M Q2 '22: -21.2M Q3 '22: -23.5M Q4 '22: -22.3M Q1 '23: -32.9M Q2 '23: -23.4M Q3 '23: -23.4M Q4 '23: -22.3M Q1 '24: -17.6M Q2 '24: -9.9M Q3 '24: -18.8M Q4 '24: -14.6M Q1 '25: -16.6M Q2 '25: -14.8M Q3 '25: -28.8M Q4 '25: -39.6M Q1 '26: -42.3M Q2 '26: -42.2M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-60M -40M -20M 0 20M 40M 60M Q1 '11: -383.7K Q2 '11: -231.4K Q3 '11: -542 Q4 '11: -1.5M Q1 '12: -1.8M Q2 '12: -1.2M Q3 '12: -1.3M Q4 '12: -1.5M Q1 '13: -1.4M Q2 '13: -761.4K Q3 '13: -2.9M Q4 '13: -3.5M Q1 '14: -4.1M Q2 '14: -5.7M Q3 '14: -5M Q4 '14: -8.3M Q1 '15: -9.1M Q2 '15: -9.3M Q3 '15: -12.4M Q4 '15: -12M Q1 '16: -15.6M Q2 '16: -8M Q3 '16: -8.4M Q4 '16: -5.4M Q3 '17: -5M Q4 '17: -4.9M Q1 '18: -6.8M Q2 '18: -5.5M Q3 '18: -4.9M Q1 '19: -8.6M Q2 '19: -4.7M Q3 '19: -6.6M Q4 '19: -6.7M Q3 '20: -19.3M Q4 '20: -18.4M Q1 '21: -21.6M Q2 '21: -20.5M Q3 '21: -20.7M Q4 '21: -48.1M Q1 '22: -51.3M Q2 '22: -35.6M Q3 '22: -32.4M Q4 '22: -27M Q1 '23: -36.7M Q2 '23: -25.2M Q3 '23: -25.2M Q4 '23: -22.8M Q1 '24: -17.7M Q2 '24: -9.9M Q3 '24: -18.8M Q4 '24: -14.6M Q1 '25: -16.6M Q2 '25: -15.4M Q3 '25: -29.7M Q4 '25: -41.5M Q1 '26: -44M Q2 '26: -42.8M Q1 '11 Q1 '13 Q1 '15 Q3 '17 Q4 '19 Q2 '22 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 100M 200M 300M Q1 '21: 290.1M Q2 '21: 10.5M Q3 '21: 11.6M Q1 '22: 16.4M Q2 '22: 3.6M Q3 '22: 6.8M Q1 '23: 10.3M Q2 '23: 576K Q3 '23: 724.2K Q1 '24: 27.9K Q2 '24: 41K Q3 '24: 626.7K Q1 '25: 5.9M Q2 '25: 7.3M Q3 '25: 8.9M Q1 '26: 13.7M Q2 '26: 16.6M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-18000.00 -12000.00 -6000.00 0.00 6000.00 12000.00 18000.00 Q4 '10: -0.18 Q1 '11: -0.21 Q2 '11: -0.23 Q3 '11: -0.28 Q4 '11: -3.24 Q1 '12: -4.48 Q2 '12: -5.47 Q3 '12: -5.47 Q4 '12: -3.83 Q1 '13: -3.49 Q2 '13: -3.43 Q3 '13: -4.25 Q4 '13: -3.39 Q1 '14: -3.05 Q2 '14: -2.71 Q3 '14: -2.55 Q4 '14: -2.74 Q1 '15: -2.86 Q2 '15: -2.98 Q3 '15: -2.99 Q4 '15: -2.87 Q1 '16: -9.57 Q2 '16: -13.81 Q3 '16: -15.99 Q4 '16: -16.17 Q1 '17: -10.03 Q2 '17: -5.71 Q3 '17: -3.58 Q4 '17: -31.89 Q1 '18: -39.42 Q2 '18: -46.00 Q3 '18: -100.22 Q4 '18: -135.36 Q1 '19: -139.32 Q2 '19: -141.51 Q3 '19: -92.21 Q4 '19: -19.33 Q1 '20: -6.94 Q2 '20: 2.25 Q3 '20: 7.85 Q4 '20: -0.75 Q1 '21: -0.45 Q2 '21: -2.47 Q3 '21: -3.98 Q4 '21: -6.00 Q1 '22: -7.54 Q2 '22: -12.93 Q3 '22: -15.57 Q4 '22: -14.92 Q1 '23: -16.52 Q2 '23: -58.11 Q3 '23: -92.50 Q4 '23: -14667.85 Q1 '24: -15200.36 Q2 '24: -17071.98 Q3 '24: -17056.03 Q4 '25: -14.44 Q1 '26: -14.53 Q2 '26: -13.11 Q2 '11 Q2 '13 Q2 '15 Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.